News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
272,613 Results
Type
Article (14377)
Company Profile (283)
Press Release (257953)
Section
Business (81273)
Career Advice (153)
Deals (13737)
Drug Delivery (35)
Drug Development (50767)
Employer Resources (31)
FDA (5853)
Job Trends (5178)
News (147319)
Policy (10315)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (6)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (914)
Accelerated approval (2)
Adcomms (12)
Allergies (48)
Alliances (22517)
ALS (54)
Alzheimer's disease (807)
Antibody-drug conjugate (ADC) (79)
Approvals (5857)
Artificial intelligence (99)
Autoimmune disease (7)
Automation (5)
Bankruptcy (102)
Best Places to Work (4593)
BIOSECURE Act (5)
Biosimilars (37)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (136)
Cancer (1167)
Cardiovascular disease (92)
Career advice (133)
Career pathing (2)
CAR-T (100)
Cell therapy (293)
Cervical cancer (5)
Clinical research (40956)
Collaboration (468)
Compensation (193)
Complete response letters (13)
COVID-19 (1034)
CRISPR (33)
C-suite (127)
Cystic fibrosis (75)
Data (1202)
Denatured (11)
Depression (26)
Diabetes (111)
Diagnostics (1371)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (71)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (60)
Earnings (29748)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (48389)
Executive appointments (374)
FDA (6398)
Featured Employer (34)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (432)
Gene editing (79)
Generative AI (9)
Gene therapy (210)
GLP-1 (342)
Government (1080)
Grass and pollen (2)
Guidances (17)
Healthcare (6707)
Huntington's disease (21)
IgA nephropathy (18)
Immunology and inflammation (70)
Indications (16)
Infectious disease (1088)
Inflammatory bowel disease (106)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (51)
Interviews (18)
IPO (7325)
IRA (11)
Job creations (881)
Job search strategy (128)
Kidney cancer (6)
Labor market (3)
Layoffs (197)
Leadership (2)
Legal (1496)
Liver cancer (28)
Lung cancer (165)
Lymphoma (75)
Machine learning (1)
Management (7)
Manufacturing (109)
MASH (46)
Medical device (2735)
Medtech (2736)
Mergers & acquisitions (6659)
Metabolic disorders (332)
Multiple sclerosis (45)
NASH (13)
Neurodegenerative disease (51)
Neuropsychiatric disorders (21)
Neuroscience (1139)
NextGen: Class of 2025 (2041)
Non-profit (853)
Northern California (1407)
Now hiring (19)
Obesity (172)
Opinion (98)
Ovarian cancer (50)
Pain (39)
Pancreatic cancer (47)
Parkinson's disease (92)
Partnered (6)
Patents (95)
Patient recruitment (54)
Peanut (35)
People (25775)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14430)
Phase II (19047)
Phase III (12043)
Pipeline (568)
Podcasts (41)
Policy (30)
Postmarket research (873)
Preclinical (6036)
Press Release (30)
Prostate cancer (49)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (258)
Real estate (1505)
Recruiting (12)
Regulatory (8659)
Reports (14)
Research institute (947)
Resumes & cover letters (17)
Rett syndrome (2)
RNA editing (1)
RSV (10)
Schizophrenia (52)
Series A (86)
Series B (51)
Service/supplier (2)
Sickle cell disease (37)
Southern California (1244)
Special edition (10)
Sponsored (11)
Startups (2001)
State (1)
Stomach cancer (4)
Supply chain (17)
The Weekly (30)
United States (11113)
Vaccines (194)
Venture capitalists (27)
Webinars (7)
Weight loss (97)
Women's health (14)
Worklife (2)
Date
Today (112)
Last 7 days (482)
Last 30 days (1707)
Last 365 days (20576)
2025 (3324)
2024 (20739)
2023 (22681)
2022 (27896)
2021 (28770)
2020 (24038)
2019 (16581)
2018 (11992)
2017 (14104)
2016 (12131)
2015 (14801)
2014 (10725)
2013 (7753)
2012 (7878)
2011 (7943)
2010 (7696)
Location
Africa (149)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17424)
Australia (2967)
California (3202)
Canada (1001)
China (284)
Colorado (123)
Connecticut (135)
Delaware (77)
Europe (39841)
Florida (373)
Georgia (94)
Idaho (17)
Illinois (202)
India (5)
Indiana (78)
Iowa (1)
Japan (66)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (10)
Maryland (416)
Massachusetts (2537)
Michigan (71)
Minnesota (124)
Mississippi (1)
Missouri (21)
Montana (14)
Nebraska (4)
Nevada (14)
New Hampshire (13)
New Jersey (802)
New Mexico (11)
New York (880)
North Carolina (494)
North Dakota (4)
Northern California (1407)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (625)
Puerto Rico (1)
Rhode Island (12)
South America (214)
South Carolina (3)
Southern California (1244)
Tennessee (24)
Texas (357)
Utah (49)
Virginia (63)
Washington D.C. (27)
Washington State (298)
Wisconsin (13)
272,613 Results for "acousia therapeutics gmbh".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Acousia Therapeutics attracts new investor on its path to make hearing loss a treatable disease
Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition to its esteemed group of investors.
January 9, 2024
·
2 min read
Drug Development
Hearing Loss Company Acousia Therapeutics Green Lighted for Game-Changing Phase 2 Trial
Acousia Therapeutics received approval from the German regulatory authorities (BfArM) for its groundbreaking Phase 2 clinical trial of the etiology-agnostic otoprotectant ACOU085 in patients with cisplatin-induced hearing loss.
October 9, 2023
·
2 min read
Press Releases
T-CURX GmbH Enters into Technology Access Agreement with Kytopen
February 14, 2025
·
5 min read
Drug Development
Hearing loss company Acousia Therapeutics completes clinical Phase 1 study with its small molecule
Hearing loss company Acousia Therapeutics GmbH announced the successful completion of its ACOU085 clinical Phase 1b study today, following the final visit of the last patient treated with the highest ACOU085 dose.
December 12, 2022
·
1 min read
Press Releases
Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm’s Innovative T Cell Therapies for Solid Cancers
February 25, 2025
·
3 min read
Deals
Great Point Partners Acquires Lyocontract GmbH, Germany-Based Drug Product CDMO
Great Point Partners, a Greenwich-based investment firm focused exclusively on the health care industry, announced the acquisition of Lyocontract GmbH, a premium independent drug product contract development and manufacturing organization based in Ilsenburg, Germany.
June 13, 2024
·
3 min read
Press Releases
Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH
January 14, 2025
·
3 min read
Business
Oakwood Chemical Announces Strategic Partnership with EMP Biotech GmbH
Oakwood Chemical is thrilled to unveil its collaboration with EMP Biotech GmbH, a move set to streamline the oligo synthesis supply chain.
April 9, 2024
·
2 min read
Press Releases
Niterra Ventures Company Invests $18M Additional Funding in Neoplas Med GmbH
November 25, 2024
·
4 min read
Drug Development
HD Immune GmbH Foundation and Publication of Latest Pre-Clinical Data
HD Immune GmbH announces commencement of operations by its two founders Dr. Stefan Bartl and Dr. Lionel Wightman.
January 23, 2024
·
2 min read
1 of 27,262
Next
